# US 2025/0144636 A1 · Methods and devices for rapid detection of covid-19 and other pathogens

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0144636 A1
- Document ID: US20250144636A1
- Status: Published application
- Kind: A1
- Application number: 18/947,820
- Filed: 2024-11-14
- Published: 2025-05-08
- Earliest claimed: 2020-11-17
- Assignees: Khalifa University of Science and Technology
- Applicants: Khalifa University of Science and Technology
- Inventors: Anas ALAZZAM; Habiba ALSAFAR; Waqas WAHEED; Sueda SAYLAN
- Web page: https://patentgrep.com/patent/US20250144636A1

## CPC

- B01L 7/52: {with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples}
- B01L 7/00: Heating or cooling apparatus (autoclaves B01J3/04); Heat insulating devices
- C12Q 1/6844: Nucleic acid amplification reactions
- C12Q 1/701: {Specific hybridization probes}
- B01L 9/06: Test-tube stands; Test-tube holders
- B01L 2200/023: adapted for different sizes of tubes, tips or container
- B01L 2200/147: Employing temperature sensors
- B01L 2300/123: Flexible; Elastomeric
- B01L 2300/1822: using Peltier elements
- B01L 2300/1827: using resistive heater
- C12Q 2600/16: Primer sets for multiplex assays
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

A device and method for detecting COVID-19 and other pathogens includes a sample compartment contained within an interior of the device and having multiple apertures for releasably receiving one or more test tubes containing a biological sample. A bottom portion of the test tube is contained within the interior of the device and a top portion of the test tube is exposed to atmosphere. The biological sample is lysed using the device; the lysed sample is mixed with one or more primers and then amplification (RT-LAMP) is performed using the device. A thermally conductive material on or in proximity to the sample compartment can facilitate precise heating of the compartment and sample. A thermally insulative material can be inside the interior of the housing. Multiple samples can be tested simultaneously. The results can be interpreted by a color change of the sample. The device is efficient, portable, reliable, and re-usable.

## Claims

### Claim 1

A method of detecting one or more pathogens using a portable, reusable device, the method comprising:
providing the device for point-of-care testing, the device comprising:
a housing formed by a plurality of interconnected walls; and
a sample compartment contained within an interior of the housing, the sample compartment having multiple apertures formed in a top surface to align with exterior apertures formed in a top wall of the housing;
placing a bottom portion of one or more test tubes containing biological samples into the multiple apertures such that the bottom portion is contained in the interior of the housing and a top portion of the one or more test tubes is exposed to atmosphere;
preheating the one or more test tubes to a predetermined temperature for a predetermined time to lyse the biological samples;
transferring at least a portion of the lysed sample from the one or more test tubes into a second test tube and mixing the lysed sample with one or more primers in the second test tube to create one or more mixtures;
performing reverse transcription loop-mediated isothermal amplification (RT-LAMP) on the one or more mixtures;
assessing a color of the one or more mixtures after the performing step to determine if the color or colors indicate a negative or positive presence of the one or more pathogens.

### Claim 2 (depends on 1)

The method of claim 1 further comprising:
adding oil to the second test tube after creating the mixture such that the oil encapsulates the mixture prior to the performing step.

### Claim 3 (depends on 1)

The method of claim 1 wherein the one or more pathogens includes SARS-COV-2.

### Claim 4 (depends on 1)

The method of claim 1 wherein the performing step comprises heating the mixture to 65° C. for thirty minutes.

### Claim 5 (depends on 1)

The method of claim 1 wherein the predetermined temperature of the preheating step is 65° C. and the predetermined time of the preheating step is ten minutes.

### Claim 6 (depends on 1)

The method of claim 1 wherein the placing step further comprises placing a bottom portion of one or more test tubes containing a positive control sample and a negative control sample into the multiple apertures such that the bottom portion is contained in the interior of the housing and a top portion of the one or more test tubes is exposed to atmosphere.

### Claim 7 (depends on 6)

The method of claim 6 wherein the assessing step comprises comparing the mixture to the positive control sample and the negative control sample concurrent to the assessing step to aid with assessing whether the color is indicative of a negative or positive presence of the one or more pathogens.

### Claim 8 (depends on 1)

The method of claim 1 wherein the device further comprises a heating source to increase a temperature of the sample compartment and the biological sample to a predetermined temperature when the test tube is received in the multiple apertures.

### Claim 9 (depends on 8)

The method of claim 8 wherein the device further comprises a thermally conductive material for use with the heating source to maintain the temperature of the sample compartment and the biological samples.

### Claim 10 (depends on 9)

The method of claim 9 wherein the thermally conductive material is located on a surface of each of the multiple apertures for proximity to the bottom portion of the one or more test tubes.

### Claim 11 (depends on 1)

The method of claim 1 further comprising:
vortexing the mixture after the transferring step and before the performing step.

### Claim 12 (depends on 1)

The method of claim 1 further comprising:
placing the mixture on ice after the performing step and before the assessing step.

### Claim 13

A method of detecting SARS-COV-2 using a portable device, the method comprising:
providing the device for point-of-care testing, the device comprising:
a housing formed by a plurality of interconnected walls; and
a sample compartment contained within an interior of the housing, the sample compartment having multiple apertures formed in a top surface to align with exterior apertures formed in a top wall of the housing;
placing a bottom portion of one or more test tubes containing biological samples into the multiple apertures such that the bottom portion is contained in the interior of the housing and a top portion of the one or more test tubes is exposed to atmosphere;
preheating the one or more test tubes to a predetermined temperature for a predetermined time to lyse the biological samples;
transferring at least a portion of the lysed sample from the one or more test tubes into a second test tube and mixing the lysed sample with one or more primers in the second test tube to create a mixture;
performing reverse transcription loop-mediated isothermal amplification (RT-LAMP) on the mixture;
assessing a color of the mixture after the performing step to determine if the color is indicative of a negative or positive presence of SARS-COV-2.

### Claim 14 (depends on 13)

The method of claim 13 further comprising:
adding oil to the second test tube after creating the mixture such that the oil encapsulates the mixture prior to the performing step.

### Claim 15 (depends on 13)

The method of claim 13 wherein the performing step comprises heating the mixture to 65° C. for thirty minutes.

### Claim 16 (depends on 13)

The method of claim 13 wherein the predetermined temperature of the preheating step is 65° C. and the predetermined time of the preheating step is ten minutes.

### Claim 17 (depends on 13)

The method of claim 13 wherein the placing step further comprises placing a bottom portion of one or more test tubes containing a positive control sample and a negative control sample into the multiple apertures such that the bottom portion is contained in the interior of the housing and a top portion of the one or more test tubes is exposed to atmosphere.

### Claim 18 (depends on 17)

The method of claim 17 wherein the assessing step comprises comparing the mixture to the positive control sample and the negative control sample concurrent to the assessing step to aid with assessing whether the color is indicative of a negative or positive presence of the one or more pathogens.

### Claim 19 (depends on 13)

The method of claim 13 further comprising:
vortexing the mixture after the transferring step and before the performing step.

### Claim 20 (depends on 13)

The method of claim 13 further comprising:
placing the mixture on ice after the performing step and before the assessing step.
